Loss of OVOL2 in Triple‐Negative Breast Cancer Promotes Fatty Acid Oxidation Fueling Stemness Characteristics
Advanced Science · 2024
DOI: 10.1002/advs.202308945 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, 2024. Verfasst von Ruipeng Lu und 12 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, 361104, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, Fatty Acids, Oxidation-Reduction, STAT3 Transcription Factor. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key R & D Project of the Ministry of Science and Technology, National Natural Science Foundation of China, Project of Xiamen Cell Therapy Research, Xiamen, Fujian, China.
Abstract (Originalsprache)
Triple‐negative breast cancer (TNBC), the most aggressive subtype of breast cancer, has a poor prognosis and lacks effective treatment strategies. Here, the study discovered that TNBC shows a decreased expression of epithelial transcription factor ovo‐like 2 (OVOL2). The loss of OVOL2 promotes fatty acid oxidation (FAO), providing additional energy and NADPH to sustain stemness characteristics, including sphere‐forming capacity and tumor initiation. Mechanistically, OVOL2 not only suppressed STAT3 phosphorylation by directly inhibiting JAK transcription but also recruited histone deacetylase 1 (HDAC1) to STAT3, thereby reducing the transcriptional activation of downstream genes carnitine palmitoyltransferase1 (CPT1A and CPT1B). PyVT‐Ovol2 knockout mice develop a higher number of primary breast tumors with accelerated growth and increased lung‐metastases. Furthermore, treatment with FAO inhibitors effectively reduces stemness characteristics of tumor cells, breast tumor initiation, and metastasis, especially in OVOL2‐deficient breast tumors. The findings suggest that targeting JAK/STAT3 pathway and FAO is a promising therapeutic strategy for OVOL2‐deficient TNBC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Cellular Stress Biology, School of Life Sciences, Xiamen University, Xiamen, 361104, China.
- Academy of Biomedical Engineering, Kunming Medical University, Kunming, 650500, China.
- The Third Affiliated Hospital, Kunming Medical University, Kunming, 650118, China.
- Department of Breast Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, 361009, China.
- Xiamen Cell Therapy Research Center, The First Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, 361003, China.
ORCID-Profile: Boan Li
Förderung
- Key R & D Project of the Ministry of Science and Technology
- National Natural Science Foundation of China
- Project of Xiamen Cell Therapy Research, Xiamen, Fujian, China
- Health-Education joint research project of Fujian province
- Project 111" sponsored by the State Bureau of Foreign Experts and Ministry of Education
Zitieren
APA
Lu, R., Hong, J., Fu, T., Zhu, Y., Tong, R., Ai, D., Wang, S., Huang, Q., Chen, C., Zhang, Z., Zhang, R., Guo, H., & Li, B. (2024). Loss of OVOL2 in Triple‐Negative Breast Cancer Promotes Fatty Acid Oxidation Fueling Stemness Characteristics. Advanced Science. https://doi.org/10.1002/advs.202308945
Vancouver
Lu R, Hong J, Fu T, Zhu Y, Tong R, Ai D, et al. Loss of OVOL2 in Triple‐Negative Breast Cancer Promotes Fatty Acid Oxidation Fueling Stemness Characteristics. Advanced Science. 2024. doi:10.1002/advs.202308945
BibTeX
@article{Lu2024,
author = {Lu, Ruipeng and Hong, Jingjing and Fu, Tong and Zhu, Yu and Tong, Ruiqi and Ai, Di and Wang, Shuai and Huang, Qingsong and Chen, Ceshi and Zhang, Zhiming and Zhang, Rui and Guo, Huiling and Li, Boan},
title = {Loss of OVOL2 in Triple‐Negative Breast Cancer Promotes Fatty Acid Oxidation Fueling Stemness Characteristics},
journal = {Advanced Science},
year = {2024},
doi = {10.1002/advs.202308945}
}
EUVIMED